Medicure (TSE:MPH) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medicure Inc. reported a slight increase in total net revenue for Q3 2024, reaching $5.2 million compared to $5.0 million in the same quarter last year. Despite a drop in AGGRASTAT sales, the company experienced growth in revenue from its Marley Drug business, contributing to a notable rise in net income to $680,000 from the previous year’s $84,000.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.